二氢麦角亭 | 3609-19-6

• 分子结构分类: 有机化合物 - 生物碱及其衍生物 - 麦角林及其衍生物
• 中文名称: 二氢麦角亭
• 英文名称: Dihydroergostin
• 英文别名: (6aR,9R,10aR)-N-[(1S,2S,4R,7S)-7-benzyl-4-ethyl-2-hydroxy-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
• CAS: 3609-19-6
• 化学式: C₃₄H₃₉N₅O₅
• 分子量: 597.7
• InChiKey: DFWHWFLWRXBPGX-UHFAATNVSA-N

物化性质

• 溶解度：
  DMSO（轻微）、甲醇（轻微、加热）、吡啶（轻微）

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  44
• 可旋转键数：
  5
• 环数：
  8.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  118
• 氢给体数：
  3
• 氢受体数：
  6

文献信息

• STABLE PHARMACEUTICAL COMPOSITIONS OF DIHYDROERGOTAMINE MESYLATE
  申请人：Slayback Pharma LLC

  公开号：US20210085657A1

  公开（公告）日：2021-03-25

  The present invention relates to stable pharmaceutical compositions of dihydroergotamine mesylate or other pharmaceutically acceptable salts thereof and methods for preparing the compositions particularly for the treatment of migraine headaches. The invention further relates to stable injectable composition comprising dihydroergotamine or its pharmaceutically acceptable salts thereof, wherein the composition has a pH from about 5.0 to about 6.0. Further, the present invention relates to a method of treating migraine comprising providing a stable pharmaceutical composition for parenteral administration comprising dihydroergotamine mesylate, wherein the pH of the composition ranges from 5.0 to 6.0 and, wherein the composition comprises no greater than 3% of total impurities as determined by HPLC.